Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview

Publisher： Karger

E-ISSN： 1423-0313|96|1-2|76-85

ISSN： 0031-7012

Source： Pharmacology, Vol.96, Iss.1-2, 2015-07, pp. : 76-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome

By Harper Ashton   Naghibi Malwina M.   Garcha Davinder  

Foods, Vol. 7, Iss. 2, 2018-01 ,pp. : 13-13

MDPI

Access to resources Recommend Favorite

Irritable Bowel Syndrome: Patient-Provider Interaction and Patient Education

By Halpert Albena  

Journal of Clinical Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 3-3

MDPI

Access to resources Recommend Favorite

Experimental Models of Irritable Bowel Syndrome and the Role of the Enteric Neurotransmission

By Vannucchi Maria Giuliana   Evangelista Stefano  

Journal of Clinical Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 4-4

MDPI

Access to resources Recommend Favorite

Irritable Bowel Syndrome: Clinical Manifestations, Dietary Influences, and Management

By Ikechi Ronald   Fischer Bradford D.   DeSipio Joshua   Phadtare Sangita  

Healthcare, Vol. 5, Iss. 2, 2017-04 ,pp. : 21-21

MDPI

Access to resources Recommend Favorite

The Gut-Brain Axis and the Microbiome: Clues to Pathophysiology and Opportunities for Novel Management Strategies in Irritable Bowel Syndrome (IBS)

By Quigley Eamonn M.M.  

Journal of Clinical Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 6-6

MDPI

Access to resources Recommend Favorite